Celltrion
068270.KS
#796
Rank
HK$194.18 B
Marketcap
HK$891.98
Share price
-4.57%
Change (1 day)
-18.49%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Dividend history for Celltrion (068270.KS)

Celltrion (stock symbol: 068270.KS) made a total of 9 dividend payments.
The sum of all dividends (adjusted for stock splits) is : HK$13.42
Dividend yield (TTM) : 0.45% See Celltrion dividend yield history

Dividend payments for Celltrion (068270.KS) from 2006 to 2024

Annual dividend payments

Year Dividend (stock split adjusted) Change
2024 HK$3.98 57.50%
2023 HK$2.53 26.98%
2022 HK$1.99-45.40%
2021 HK$3.64 3,764.42%
2012 HK$0.09429-77.75%
2011 HK$0.42 26.98%
2010 HK$0.33 57.50%
2007 HK$0.21-4.76%
2006 HK$0.22N/A

List of all dividend payments

Date Dividend (stock split adjusted) Change
2024-12-27HK$3.98 57.50%
2023-12-27HK$2.53 26.98%
2022-12-28HK$1.99-45.40%
2021-12-29HK$3.64 3,764.42%
2012-12-27HK$0.09429-77.75%
2011-12-28HK$0.42 26.98%
2010-12-29HK$0.33 57.50%
2007-12-27HK$0.21-4.76%
2006-12-27HK$0.22N/A